Αρχειοθήκη ιστολογίου

Τετάρτη 21 Μαρτίου 2018

FDA Issues Update on Rare Breast Implant-Associated Lymphoma

As of September 30, 2017, the FDA has received a total of 414 medical device reports of anaplastic large cell lymphoma associated with breast implants, most involving implants with textured surfaces.
News Alerts

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2IGMDR5

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου